WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007007344) INACTIVATED POLIOMYELITIS VACCINE DERIVED FROM SABIN STRAIN OF POLIO VIRUS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/007344    International Application No.:    PCT/IN2004/000267
Publication Date: 18.01.2007 International Filing Date: 27.08.2004
IPC:
A61K 39/13 (2006.01)
Applicants: PANACEA BIOTEC LTD. [IN/IN]; B-1 Extn./A-27, Mohan Co-operative Industrial Estate, Mathura Road, New Delhi 110 044 (IN) (For All Designated States Except US).
JAIN, Rajesh [IN/IN]; (IN) (For US Only).
CHAWLA, Anil [IN/IN]; (IN) (For US Only).
KUMRAJ, Ganesh [IN/IN]; (IN) (For US Only)
Inventors: JAIN, Rajesh; (IN).
CHAWLA, Anil; (IN).
KUMRAJ, Ganesh; (IN)
Priority Data:
Title (EN) INACTIVATED POLIOMYELITIS VACCINE DERIVED FROM SABIN STRAIN OF POLIO VIRUS
(FR) VACCIN ANTIPOLIOMYÉLITIQUE INACTIVÉ DÉRIVÉ DE LA SOUCHE SABIN DU VIRUS DE LA POLIO
Abstract: front page image
(EN)An inactivated Polio Vaccine derived from Sabin strain for safe and effective immunization against Poliomyelitis is provided. A process of preparation for such vaccine and formulations thereof are also provided. Administration of the vaccine of the present invention along with other antigens provides immunization not only against polio infection but also against other pathogens causing Hepatitis C. Hepatitis D. Hepatitis E. Meningitis A. Meningitis B. Meningitis C. Meningitis W. Meningitis Y. Pnemococcal (23 valent or more). Smallpox, Typhoid, Bacille Calmette Guerin, Tuberculosis. Human Immunodeficiency Virus. Anthrax or the like, to which children or adults not immunized earlier are susceptible, particularly to which children are susceptible.
(FR)L'invention concerne un vaccin inactivé de la polio dérivé d'une souche Sabin pour une immunisation sécurisée et efficace contre la poliomyélite. Elle concerne aussi un processus de préparation d'un tel vaccin et ses formulations. L'administration du vaccin selon la présente invention avec d'autres antigènes confère une immunisation non seulement contre l'infection par la polio, mais aussi contre d'autres pathogènes entraînant l'hépatite C. l'hépatite D. l'hépatite E. la méningite A. la méningite B. la méningite C. la méningite W. la méningite Y. le pneumocoque (23 de valence ou plus). la variole, la typhoïde, le bacille de Calmette Guérin, la tuberculose. le virus d'immunodéficience humain. l'anthrax ou similaire, face auxquels les enfants et les adultes non immunisés préalablement sont fragilisés, en particulier les enfants.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)